 |
|
Advanced therapy offers cure for relapsed cancer patient
July 26, 2007INDIANAPOLIS -- Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses of cisplatin, first used successfully in the treatment of this disease by Lawrence Einhorn, M.D., at Indiana University Cancer Center in the early 1980s. That course of therapy turned a disease from a mostly fatal cancer into one of the more curable forms of cancer for men, who typically are in their 20s when diagnosed with testicular cancer.
It is rare for the NEJM to carry a retrospective study from a single institution that is not a randomized study. This review looks at the outcome of 184 patients with metastatic testicular cancer. Dr. Einhorn and colleagues demonstrated that the disease is potentially curable with a high dose chemotherapy and stem cell transplant using cells harvested from the patient before the initial chemotherapy infusion.
The patients received carboplatin chemotherapy at five times the dosage administered to men receiving initial therapy. A side effect of the high dosage is a reduction of blood cells so a stem cell transplant is given to replenish the body's immune system through a process similar to a blood transfusion. Three to four weeks later the entire process is repeated.
"The message for patients is that through research, diligence and new technologies there is hope," said Dr. Einhorn, professor of medicine at the Indiana University Melvin and Bren Simon Cancer Center and the lead author of the study. "The bar is steadily being raised and more patients are being saved."
"This review confirms that high-dose chemotherapy combined with a stem cell transplant can provide a cure for a group of patients with relapsed testicular cancer," said Rafat Abonour, M.D., associate professor of medicine in the division of hematology/oncology and associate dean for clinical research at the IU School of Medicine.
Although the number of relapsed testicular cancer patients is small, the IU Simon Cancer Center treats a majority of them. As a leader in this treatment, the researchers were able to collect the necessary data for the NEJM retrospective.
For the patients each year who are treated with this therapy, there is renewed hope. "This is new medicine and it tells patients that cures are on the horizon," said Stephen D. Williams, M.D., director of the IU Simon Cancer Center and a co-author of the paper.
Indiana University
The patients received carboplatin chemotherapy at five times the dosage administered to men receiving initial therapy. A side effect of the high dosage is a reduction of blood cells so a stem cell transplant is given to replenish the body's immune system through a process similar to a blood transfusion. Three to four weeks later the entire process is repeated.
"The message for patients is that through research, diligence and new technologies there is hope," said Dr. Einhorn, professor of medicine at the Indiana University Melvin and Bren Simon Cancer Center and the lead author of the study. "The bar is steadily being raised and more patients are being saved."
"This review confirms that high-dose chemotherapy combined with a stem cell transplant can provide a cure for a group of patients with relapsed testicular cancer," said Rafat Abonour, M.D., associate professor of medicine in the division of hematology/oncology and associate dean for clinical research at the IU School of Medicine.
Although the number of relapsed testicular cancer patients is small, the IU Simon Cancer Center treats a majority of them. As a leader in this treatment, the researchers were able to collect the necessary data for the NEJM retrospective.
For the patients each year who are treated with this therapy, there is renewed hope. "This is new medicine and it tells patients that cures are on the horizon," said Stephen D. Williams, M.D., director of the IU Simon Cancer Center and a co-author of the paper.
Indiana University
Testicular Cancer Current Events and Testicular Cancer News RSSLow sperm count may be associated with prenatal testosterone excess
Exposure to an excess of sexual steroids, like testosterone, during fetal development may be a potential risk factor for low sperm count and motility.
Maternal exposure to persistent organic pollutants linked to urologic conditions in boys
Higher incidences of congenital anomalies, including cryptorchidism (undescended testicles) and hypospadias, were found in boys whose mothers had higher serum levels of certain organochlorine compounds, researchers say.
IUPUI scientists report first 3-D view of anti-cancer agent
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
Testicular cancer gauge often not used
A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center have found.
Couples more likely to divorce if spouse develops cervical or testicular cancer
In the largest and most rigorous study to date investigating how cancer influences divorce, Norwegian researchers have found that marriages are no more likely than normal to break down unless a spouse develops cervical or testicular cancer.
Stem cells derived from adult testes produce wide range of tissue types
After a decade of research, Howard Hughes Medical Institute scientists have succeeded in reprogramming adult stem cells from the testes of male mice into functional blood vessels and contractile cardiac tissue.
Reversing cancer cells to normal cells
In earlier work, Northwestern University scientist Mary J.C. Hendrix and colleagues discovered that aggressive melanoma cells (but not normal skin cells nor less aggressive melanoma cells) contain specific proteins similar to those found in embryonic stem cells.
Exposure to dioxins influences male reproductive system, study of Vietnam veterans concludes
A dioxin toxin contained in the herbicide Agent Orange affects male reproductive health by limiting the growth of the prostate gland and lowering testosterone levels.
Firefighters face increased risk for certain cancers
University of Cincinnati (UC) environmental health researchers have determined that firefighters are significantly more likely to develop four different types of cancer than workers in other fields.
UVA studies potential target for skin cancer treatment
When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin.
More Testicular Cancer Current Events and Testicular Cancer News Articles
 | One Lump or Two?: A Humourous Story of One Man's Fight Against Testicular Cancer by Darren Couchman Full of emotion, inspiration and bags of laughter, this story tells the unique way of how an ordinary bloke dealt with the terrifying news of having testicular... |
 | Frequently Asked Questions About Testicular Cancer (Faq: Teen Life) by Paula Johanson |
 | The Official Patient's Sourcebook on Testicular Cancer: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to testicular cancer (also Cancer testes; Hematocele; Hydrocele;... |
 | Y chromosome instability in testicular cancer [An article from: Mutation Research-Reviews in Mutation Research] by N.O. Bianchi, S.M. Richard, W. Pavicic This digital document is a journal article from Mutation Research-Reviews in Mutation Research, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Approximately 15-25% of male infertility cases carry extensive azoospermic factor (AZF) deletions.... |
 | Testicular Cancer, An Issue of Urologic Clinics (The Clinics: Surgery) by Joel Sheinfeld Each year there are approximately 8000 new cases of testicular cancer diagnosed in the United States, resulting in almost 400 deaths. The incidence of testicular cancer, the most common solid tumor in men between the ages of 20 and 35 years, is rising in the United States and Europe. The management of patients with testicular cancer has evolved significantly over the past 25 years, representing a... |
 | Testicular Cancer: Investigation and Management The Royal Marsden NHS Trust, Surrey, U.K. Text on testicular germ cell tumors, for oncologists and urologists. New chapters discuss the clinical relevance of current research and controversies such as management of Stage II non-seminoma. Previous edition 1991. 38 contributors, 11... |
 | A comparison of breast, testicular and prostate cancer in mass print media (1996-2001) [An article from: Social Science & Medicine] by J.N. Clarke This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: This paper compares the portrayal of breast, testicular and prostate cancer in mass print English language magazines in the... |
| (Dis)embodying gender and sexuality in testicular cancer [An article from: Social Science & Medicine] by M. Gurevich, S. Bishop, J. Bower, M. Malka, Nyhof- This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Testicular cancer is the most common cancer in men aged 15-34. Although post-treatment prognosis is generally very good, the... |
| Gale Encyclopedia of Medicine: Testicular cancer by Deanna M. Swartout-Corbeil R.N. The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major... | |
 | Renal, Bladder, Prostate and Testicular Cancer: An Update This cutting-edge clinical reference presents the latest findings and procedures concerning the diagnosis, treatment, management, and prognosis of renal, bladder, prostate and testicular cancer. Leading international authorities deal with the full range of clinical issues of paramount importance in oncological urology. They cover testicular cancer, renal cell and transitional cell carcinoma, new... |
| © 2008 BrightSurf.com |